I agree, Doc. I feel the same. Although, I can wait on AltuCell. I’m personally more focused on seeing an actual beginning of the Phase I study for Ii-key/Covid and the spin out of NGIO. I actually don’t feel interested in hearing about MSOs, Excelagen or anything else to muddy clear waters. We need to focus. Rather Generex needs to laser focus. Move this forward, nor just radio interviews, Facebook posts from Joe against mRnai approach, but capitalize on today’s success by moving the Covid vaccine significantly forward. Capital has come in. Now start a human study.